Alex K Bryant

14PUBLICATIONS
66CO-AUTHORS
Predictive and prognostic markersDeep learningImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 18, 2026
Maintenance Pemetrexed/Pembrolizumab Versus Pembrolizumab in Non-Small Cell Lung Cancer: A Propensity Score-Weighted Analysis.

|Jun 12, 2026
Phenotyping Prostate Cancer in a National Health System Using Large Language Models.

|Jun 04, 2026
Polygenic risk scores for prediction of immune checkpoint inhibitor thyroid toxicity in diverse populations.

|Dec 14, 2025
The effect of common medications on the efficacy of immune checkpoint inhibitors.

Daria Brinzevich, Virginia Falvello, Sadiq S Rehmani

|Sep 04, 2025
Liver Metastases License Neutrophils through IL1 to Potentiate Cancer Progression.

Ashley N Pearson, Jessica Waninger, Amanda K Huber

|Nov 07, 2024
Pan-Cancer Survival Impact of Immune Checkpoint Inhibitors in a National Healthcare System.

Sean R Miller, Matthew Schipper, Lars G Fritsche

Pageof 3

Frequent Collaborators

6 joint publications

Michael D Green

2 joint publications

Rishi Deka

2 joint publications

Garth W Strohbehn

2 joint publications

Silvia Crivelli